DK0835137T3 - Indkapslede celler, som danner viruspartikler - Google Patents
Indkapslede celler, som danner viruspartiklerInfo
- Publication number
- DK0835137T3 DK0835137T3 DK96923905T DK96923905T DK0835137T3 DK 0835137 T3 DK0835137 T3 DK 0835137T3 DK 96923905 T DK96923905 T DK 96923905T DK 96923905 T DK96923905 T DK 96923905T DK 0835137 T3 DK0835137 T3 DK 0835137T3
- Authority
- DK
- Denmark
- Prior art keywords
- encapsulated cells
- virus particles
- form virus
- cells
- genes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK74095 | 1995-06-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0835137T3 true DK0835137T3 (da) | 2006-03-06 |
Family
ID=8097001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96923905T DK0835137T3 (da) | 1995-06-27 | 1996-06-24 | Indkapslede celler, som danner viruspartikler |
Country Status (22)
Country | Link |
---|---|
US (1) | US6776985B1 (da) |
EP (1) | EP0835137B1 (da) |
JP (2) | JP4119952B2 (da) |
KR (1) | KR100484883B1 (da) |
CN (1) | CN1187095C (da) |
AT (1) | ATE309000T1 (da) |
AU (1) | AU708273B2 (da) |
CA (1) | CA2222559A1 (da) |
CZ (1) | CZ286979B6 (da) |
DE (1) | DE69633180D1 (da) |
DK (1) | DK0835137T3 (da) |
ES (1) | ES2253754T3 (da) |
HK (1) | HK1010139A1 (da) |
IL (1) | IL122119A (da) |
NO (1) | NO321427B1 (da) |
NZ (1) | NZ312671A (da) |
PL (1) | PL185338B1 (da) |
PT (1) | PT835137E (da) |
RU (1) | RU2187301C2 (da) |
SI (1) | SI0835137T1 (da) |
UA (1) | UA65525C2 (da) |
WO (1) | WO1997001357A1 (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0817858T3 (da) | 1995-03-09 | 2003-08-11 | Gsf Forschungszentrum Umwelt | Vektorer, som indeholder terapeutiske gener for antimikrobielle peptider, til anvendelse ved genterapi |
AU708273B2 (en) | 1995-06-27 | 1999-07-29 | Bavarian Nordic A/S | Encapsulated cells producing viral particles |
US6540995B1 (en) | 1996-03-27 | 2003-04-01 | Bavarian Nordic Research Institute Gmbh | Encapsulated cells producing cytochrome P450 |
RU2223788C2 (ru) | 1996-03-27 | 2004-02-20 | Бавариан Нордик Рисерч Инститьют А/С | Трансдуцирующие цитохром p450 ретровирусные векторы |
WO1999056660A1 (en) | 1998-05-05 | 1999-11-11 | Koninklijke Philips Electronics N.V. | Toothbrush comprising a brush member having a bristle field and an interdental bristle field |
CN1950397B (zh) | 2004-03-30 | 2012-05-16 | Ns基因公司 | 生长因子NsG33的治疗用途 |
CA2606858A1 (en) | 2005-05-03 | 2006-11-09 | Veterinarmedizinische Universitat Wien | Permeable capsules |
AU2008343193B2 (en) | 2007-12-20 | 2014-04-24 | Ethicon, Incorporated | Encapsulated kidney tissue |
KR101250925B1 (ko) * | 2011-10-28 | 2013-04-04 | 한화케미칼 주식회사 | 캡슐 세포용 구조체 |
GB201408233D0 (en) | 2014-05-09 | 2014-06-25 | Austrianova Singapore Pte Ltd | Use of polyanionic composition |
ES2939617T3 (es) * | 2015-11-24 | 2023-04-25 | Glaxosmithkline Ip Dev Ltd | Líneas celulares estables para producción retroviral |
DE102016122317A1 (de) * | 2015-11-24 | 2017-05-24 | Glaxosmithkline Intellectual Property Development Limited | Transientes transfektionsverfahren für retrovirale produktion |
WO2017205573A1 (en) | 2016-05-25 | 2017-11-30 | Lonza Houston Inc. | Methods for isolating adeno-associated virus using a polydiallyldialkylammonium salt |
RU2688383C2 (ru) * | 2017-07-10 | 2019-05-21 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский национальный исследовательский государственный университет имени Н.Г. Чернышевского" | Способ синтеза белка в культуре бактериальных клеток |
CN110615667B (zh) * | 2018-06-19 | 2022-02-15 | 华北理工大学 | 基于铁尾矿和碱渣的核壳结构陶粒及其制备方法 |
JP2024519909A (ja) * | 2021-05-21 | 2024-05-21 | バイオナット ラブス リミテッド | マイクロボット媒介治療送達のためのシステム及び方法 |
CN115820683B (zh) * | 2022-09-28 | 2024-04-05 | 西南大学 | 家蚕Cyp9a20基因及其应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4391909A (en) * | 1979-03-28 | 1983-07-05 | Damon Corporation | Microcapsules containing viable tissue cells |
DD160393A3 (de) * | 1980-11-14 | 1983-07-27 | Horst Dautzenberg | Mikrokapseln und verfahren zu ihrer herstellung |
US4686098A (en) * | 1984-05-14 | 1987-08-11 | Merck & Co., Inc. | Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivo |
US4680174A (en) * | 1984-05-24 | 1987-07-14 | Damon Biotech, Inc. | Induction of immune response by immunization with encapsulated antigen-producing cells |
EP0199362A3 (en) * | 1985-04-26 | 1987-10-07 | Massachusetts Institute Of Technology | System and apparatus for delayed and pulsed release of biologically active substances |
CA1310924C (en) * | 1986-04-24 | 1992-12-01 | Francis P. Mccormick | Infective drug delivery system |
DE68927089T2 (de) | 1988-05-17 | 1997-04-03 | Sloan Kettering Inst Cancer | Retroviraler vektor |
US5328470A (en) * | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
DE4021050A1 (de) * | 1990-06-29 | 1992-01-02 | Akad Wissenschaften Ddr | Verfahren zur herstellung von mikrokapseln |
CA2051288C (en) * | 1990-09-14 | 2002-02-05 | Robert L. Martuza | Viral targeted destruction of neoplastic cells |
WO1992010564A1 (en) * | 1990-12-13 | 1992-06-25 | The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce | Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy |
WO1994029437A1 (en) | 1993-06-07 | 1994-12-22 | University Of Medicine & Dentistry Of New Jersey | Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors |
US5688773A (en) | 1994-08-17 | 1997-11-18 | The General Hospital Corporation | Method of selectively destroying neoplastic cells |
JP4037446B2 (ja) | 1994-09-02 | 2008-01-23 | ゲーエスエフ − フォルシュンクスツェントルム・フューア・ウムベルト・ウント・ゲズントハイト・ゲーエムベーハー | 非自己不活化性の発現標的化レトロウイルスベクタ |
AU708273B2 (en) | 1995-06-27 | 1999-07-29 | Bavarian Nordic A/S | Encapsulated cells producing viral particles |
ES2174103T3 (es) | 1995-09-06 | 2002-11-01 | Austrian Nordic Biotherapeutic | Uso de las secuencias reguladoras de wap o mmtv para expresion dirigida de genes heterologos ligados en celulas mamarias humanas, con inclusion de celulas de carcinoma mamario humano. |
RU2223788C2 (ru) | 1996-03-27 | 2004-02-20 | Бавариан Нордик Рисерч Инститьют А/С | Трансдуцирующие цитохром p450 ретровирусные векторы |
-
1996
- 1996-06-24 AU AU64154/96A patent/AU708273B2/en not_active Expired
- 1996-06-24 AT AT96923905T patent/ATE309000T1/de not_active IP Right Cessation
- 1996-06-24 CZ CZ19974195A patent/CZ286979B6/cs not_active IP Right Cessation
- 1996-06-24 SI SI9630729T patent/SI0835137T1/sl unknown
- 1996-06-24 CA CA002222559A patent/CA2222559A1/en not_active Abandoned
- 1996-06-24 ES ES96923905T patent/ES2253754T3/es not_active Expired - Lifetime
- 1996-06-24 NZ NZ312671A patent/NZ312671A/xx not_active IP Right Cessation
- 1996-06-24 WO PCT/EP1996/002748 patent/WO1997001357A1/en active IP Right Grant
- 1996-06-24 JP JP50416597A patent/JP4119952B2/ja not_active Expired - Lifetime
- 1996-06-24 PT PT96923905T patent/PT835137E/pt unknown
- 1996-06-24 RU RU98101362/13A patent/RU2187301C2/ru not_active IP Right Cessation
- 1996-06-24 KR KR1019970709807A patent/KR100484883B1/ko not_active IP Right Cessation
- 1996-06-24 PL PL96324289A patent/PL185338B1/pl not_active IP Right Cessation
- 1996-06-24 DE DE69633180T patent/DE69633180D1/de not_active Expired - Lifetime
- 1996-06-24 CN CNB961950501A patent/CN1187095C/zh not_active Expired - Fee Related
- 1996-06-24 DK DK96923905T patent/DK0835137T3/da active
- 1996-06-24 UA UA97126354A patent/UA65525C2/uk unknown
- 1996-06-24 IL IL12211996A patent/IL122119A/en not_active IP Right Cessation
- 1996-06-24 EP EP96923905A patent/EP0835137B1/en not_active Expired - Lifetime
-
1997
- 1997-12-10 NO NO19975813A patent/NO321427B1/no not_active IP Right Cessation
- 1997-12-23 US US08/996,460 patent/US6776985B1/en not_active Expired - Lifetime
-
1998
- 1998-09-26 HK HK98110992A patent/HK1010139A1/xx not_active IP Right Cessation
-
2007
- 2007-11-21 JP JP2007301109A patent/JP4848348B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1997001357A1 (en) | 1997-01-16 |
RU2187301C2 (ru) | 2002-08-20 |
AU708273B2 (en) | 1999-07-29 |
CA2222559A1 (en) | 1997-01-16 |
PL185338B1 (pl) | 2003-04-30 |
US6776985B1 (en) | 2004-08-17 |
UA65525C2 (en) | 2004-04-15 |
PL324289A1 (en) | 1998-05-11 |
IL122119A0 (en) | 1998-04-05 |
NZ312671A (en) | 1999-10-28 |
JP2008101011A (ja) | 2008-05-01 |
KR19990028491A (ko) | 1999-04-15 |
IL122119A (en) | 2004-06-01 |
NO975813L (no) | 1998-02-23 |
EP0835137B1 (en) | 2005-11-09 |
ATE309000T1 (de) | 2005-11-15 |
JP4848348B2 (ja) | 2011-12-28 |
CN1189104A (zh) | 1998-07-29 |
HK1010139A1 (en) | 1999-06-17 |
AU6415496A (en) | 1997-01-30 |
CN1187095C (zh) | 2005-02-02 |
SI0835137T1 (sl) | 2006-04-30 |
CZ419597A3 (cs) | 1998-03-18 |
ES2253754T3 (es) | 2006-06-01 |
JP4119952B2 (ja) | 2008-07-16 |
PT835137E (pt) | 2004-12-31 |
JPH11508768A (ja) | 1999-08-03 |
EP0835137A1 (en) | 1998-04-15 |
DE69633180D1 (de) | 2004-09-23 |
CZ286979B6 (en) | 2000-08-16 |
NO321427B1 (no) | 2006-05-08 |
KR100484883B1 (ko) | 2005-09-02 |
NO975813D0 (no) | 1997-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0835137T3 (da) | Indkapslede celler, som danner viruspartikler | |
CA2092195A1 (en) | Retroviral packaging cell line | |
CA2154023A1 (en) | Recombinant infectious non-segmented negative strand rna virus | |
DE69435316D1 (de) | Verfahren zur herstellung von hohen virustitern und die hocheffiziente transduktion von säugerzellen durch retroviren | |
WO1991002805A3 (en) | Recombinant retroviruses delivering vector constructs to target cells | |
ES2075901T3 (es) | Sistemas de expresion de virus recombinantes de arn con cadena negativa y vacunas. | |
AU6871398A (en) | Method for enhancing expression of a foreign or endogenous gene product in pla nts | |
DE59410380D1 (de) | Endosomolytisch wirksame partikel | |
WO1996013597A3 (en) | Improved adenovirus and methods of use thereof | |
CY1105963T1 (el) | Συνθεσεις καψομepιδιακου εμβολιου του ιου του θηλωματος και μεθοδοι χρησης | |
MY123970A (en) | Catalyst component comprising magnesium, titanium, a halogen and an electron donor, its preparation and use | |
GB9020586D0 (en) | Recombinant retroviruses | |
DE69420034T2 (de) | Synthetische mischpeptide, die die entstehung von neutralisierenden antikörpern und die wirkung der cytotoxischen t-lymphozyten gegen hiv hervorufen | |
AU6704496A (en) | Helper viruses for the preparation of recombinant viral vectors | |
EP1006196A3 (de) | Retrovirale, mit LCMV-Glykoprotein pseudotypisierte Hybrid-Vektoren | |
AU1022999A (en) | 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs | |
DK0843731T3 (da) | Adenovirusvektorer til genterapi | |
CA2263790A1 (en) | Method for immortalizing cells | |
RU2006123079A (ru) | Вирусные частицы, содержащие вектор, происходящий из альфавируса, и способ получения указанной вирусной частицы | |
YU48200A (sh) | Farmaceutski preparati | |
NZ507942A (en) | Viral chimeras comprised of CAEV and HIV-1 genetic elements | |
CA2331440A1 (en) | Amphotropic retrovirus packaging cell line, process for its production and use thereof | |
FR2650954B1 (fr) | Composition resultant de la reunion d'un epitope b de la glycoproteine d'enveloppe d'un retrovirus du type iv et d'un epitope t issu d'une proteine distincte codee par ce retrovirus et leur application a la production d'anticorps protecteurs contre le sida | |
JP2002513546A5 (da) | ||
AU1275095A (en) | Antiviral composition of viral protein trans-dominant variants |